Retatrutide, by Soma Pharmaceuticals , is attracting significant attention as a innovative method for metabolic management . This innovative medication merges the mechanism of a GLP-1 receptor stimulant and a GIP receptor activator , aiming to not only promote metabolic improvements but also improve related metabolic conditions . Preliminary patien